Annovis Bio Stock Discussion

$Annovis Bio (ANVS.US)$
Annovis Bio Inc. (NYSE: ANVS) Research Points to Potential Future Breakthroughs in AD Space Through Innovative Combinations
Annovis Bio Inc. (NYSE: ANVS) has announced promising early research results for its lead drug, buntanetap, in combination with other approved drugs for Alzheimer's disease (AD) treatment. While recent FDA-approved drugs like Leqembi and Kisunla may slow cognitive decline in AD patients, they do not improve cognition. Similarly, GLP-1 drugs, origi...

$Annovis Bio (ANVS.US)$
Annovis Files Three New Patents for Combination Therapies Involving Buntanetap, Trulicity, and Viagra
Annovis Bio Inc. (NYSE: ANVS) has filed three new patents for innovative combination therapies involving its lead compound, buntanetap. These patents cover combinations of buntanetap with Trulicity (dulaglutide), Viagra (sildenafil), or a combination of all three, aimed at treating neurodegenerative diseases like Alzheimer's and Parkinson's.
Recent preclinical studies ...

$Annovis Bio (ANVS.US)$ so how do I file a fraud complaint against this company?

$Annovis Bio (ANVS.US)$ Almost 16% SI. HTB list with a CTB 162.40% and only 150K shares LTB

$Annovis Bio (ANVS.US)$ Annovis Bio Secures U.S. Patent for Treatment of Acute Traumatic Brain Injury With Buntanetap